Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma. Semin Intervent Radiol 2013 Mar;30(1):21-7

Date

01/18/2014

Pubmed ID

24436514

Pubmed Central ID

PMC3700793

DOI

10.1055/s-0033-1333650

Abstract

Cholangiocarcinoma, whether arising from the intrahepatic or extrahepatic biliary system, is a rare but devastating malignancy. Prognosis is poor, with 5-year overall survival <5% including patients undergoing surgery. Resection is the only curative treatment; however, only ∼30% of patients present at a resectable stage, and intrahepatic recurrence is common even after complete resection. This article discusses the current role of transarterial therapies in the treatment of intrahepatic cholangiocarcinoma.

Author List

Zechlinski JJ, Rilling WS

Author

William S. Rilling MD Vice Chair, Professor in the Radiology department at Medical College of Wisconsin




jenkins-FCD Prod-398 336d56a365602aa89dcc112f077233607d6a5abc